Spiros N. Agathos, Ph.D. is Professor of Bioengineering at the Université Catholique de Louvain (UCL) in Louvain-la-Neuve, Belgium since 1993 and, since 2015, he is Inaugural Dean of Biological Sciences and Engineering at Yachay Tech, the first research-intensive university in Ecuador and a hub of innovation in South America.
He is an expert in Biotechnology and Bioengineering, with interests in biocatalyst development, bioprocess optimisation, bioreactor design and scale-up, ecogenomics, and biotechnology for sustainability. He has a PhD in biochemical engineering from the Massachusetts Institute of Technology (MIT) and served on the faculties of the University of Western Ontario (Canada) and Rutgers University (New Jersey, USA) and as a visiting professor in Europe and the Americas.
He has published over 200 articles, 4 books and 4 patents. He has been Editor or Editorial Board member of many journals and serves on numerous committees for science and technology policy. He is a consultant to governments and industry, while his former students and postdocs have significant academic and industrial positions across the globe. Among his many awards, he is an elected Fellow of the American Institute for Medical & Biological Engineering (AIMBE), of the Society for Industrial Microbiology & Biotechnology (SIMB) and of the International Water Association (IWA).
Associate Prof. of Bioengineering, University of Pisa, Head of In-Vitro Models Group and NanoBioscopy Lab at the National Council of Research Institute of Clinical Physiology (CNR-IFC). Also involved in capacity building in the field of Biomedical Engineering, in association with UNECA and FABLAB Pisa .Author of over 100 peer-reviewed publications and of several patents on microfabrication and on bioreactors, co-founder of 2 high-tech companies.
Training: Dentistry, Biomedical Research, Bioengineering, Pathology
Postdoctoral: TGF-beta, wound healing, regeneration, radiation biology, light biology, stem cells, biomaterial, Lasers.
Current: Clinical translational research and molecular mechanism.
Positions: Past-President, NAALT; President-Elect WALT, Co-Chair SPIE, Chair, ASLMS
Interests: Signal Transduction, Lasers, Biological regulation, Photobiomodulation.
I am currently working as Asscociate research scientist at Yale University. Previously I worked as Postdoctoral fellow at National Institutes of Health, USA. My current work is on infectious diseases such as malaria, tuberculosis, Lyme, Anthrax. In my project, I study immune correlates of protection to malaria. I have about 10 years of post-PhD experience in Global health, Immunology and Microbiology. I did my PhD from CSIR-Institute of Genomics and Integrative Biology, Delhi, India working on bacterial pathogens M. tuberculosis and other gram-positive bacterial pathogens. I worked as Vaccine Research Innovation awardee at Translational Health Science and Technology Institute in India.
I have 26 publications in International peer-reviewed journals and have published 4 Book chapters. My current h-index is 18. In the recent past, I have served as reviewer for Frontiers Journal, MDPI journals, Nature press journals, Medicine, Pathogen and vectors, BMC Microbiology, Archives of Microbiology, Journal of Antimicrobial Chemotherapy, and Indian Journal of Microbiology.
Professor of Genetics and Deputy Head of the Department of Genetics, Ecology and Evolution. He is a member of the Brazilian Academy of Sciences and is a Knight of the National Order of Scientific Merit of the Brazilian Ministry of Science, Technology and Innovation. Researcher 1A of the National Council for Scientific and Technological Development (CNPq) which is the highest position.
Valentina E. Balas is currently Full Professor at the Faculty of Engineering, “Aurel Vlaicu” University of Arad, Romania.
She holds a Ph.D. in Applied Electronics and Telecommunications from Polytechnic University of Timisoara. Dr. Balas is author of more than 350 research papers. Her research interests are in Intelligent Systems, Fuzzy Control, Soft Computing.
She is the Editor-in Chief to IJAIP and to IJCSysE, and is evaluator expert for national, international projects.
Dr. Balas is the director of Intelligent Systems Research Centre in Aurel Vlaicu University of Arad and Director of the Department of International Relations.
She served as General Chair of SOFA conferences in nine editions organized in the interval 2005-2020 and held in Romania and Hungary.
Dr. Balas participated in many international conferences as Organizer, Honorary Chair, Session Chair, member in Steering, Advisory or International Program Committees and Keynote Speaker.
She is a member of EUSFLAT, member of SIAM and a Senior Member IEEE, member in TC Fuzzy Systems (IEEE CIS), chair of the Task Force 14 in TC Emergent Technologies (IEEE CIS), member in TC Soft Computing (IEEE SMCS).
Dr. Balas was past Vice-president ( Awards) of IFSA -(2013-2015), is a Joint Secretary of the Governing Council of Forum for Interdisciplinary Mathematics, and recipient of the "Tudor Tanasescu" Prize from the Romanian Academy (2019).
INSERM Tenured Researcher in the field of Cardiovascular Research, currently focusing on therapeutic angiogenesis with polymer-based targeted growth factor delivery.
PhD in Tumor Biology (Pr Yihai Cao, Karolinska Institutet, Sweden), and expertise in Adipose tissue angiogenesis. Postdoc at UCLA (Pr Lily Wu) in molecular imaging and tumor lymphangiogenesis field.
Member of European Vascular Biology Organisation, French society for Cardiovascular Research, French society for Angiogenesis Research.
PhD. Jesús Campos-García.
Professor-Researcher of Microbial Biotechnology Laboratory since 2003, at the Research Institute of Biological Chemistry of the Universidad Michoacana de San Nicolás de Hidalgo, México. He has authored over 60 papers in indexed and peer-reviewed journals. He was recipient of the National Award for young Researchers in 1998, for the Mexican Academy of Science. He possesses three Patents and two in process.
Research areas are related with the study of the mechanisms of interaction of microorganisms such as Pseudomonas aeruginosa with the environment: mechanisms of organic compounds degradation, heavy metals resistance, host-pathogen interaction, microbial nano-bioactive metabolites, and genetic modification of industrial GEMs used for alcoholic fermentation.
•National Award for young Researchers in 1998, for the Mexican Academy of Science.
•State Award of Scientific Research in 2009, Michoacán State Government, México.
•Grant Marcos Moshinsky 2013-2014, Chemistry-Biological Sciences. Marcos Moshinsky Funding, México.
•Weizmann Award 2015, Nature Science. Mexican Academy of Science, to Randy Ortíz Castro by PhD thesis: Study of the N-acil-L-homoserin lactones and cyclodipeptides from bacteria of Pseudomonas genus in the plant development regulation.
•Member of the Mexican Academy of Science (since 2008).
•Member of the National System of Researchers (S.N.I.) since 1996.
E. Ada Cavalcanti-Adam is a research group leader at the Institute of Physical Chemistry, University of Heidelberg and head of Central Scientific Facility “Biomaterials and Molecular Biology” at the Max Planck Institute for Intelligent Systems in Stuttgart. Her main research interest is on extracellular stimuli which guide cell structure and functions with a special focus on the role of growth factors on cell adhesion and migration.
Professor of Biomedical Engineering, Mechanical Engineering at The University of Hong Kong.
Albert Cheng obtained his BSc in Biochemistry and MPhil in Biology from Hong Kong University of Science and Technology in 2005 and 2007, respectively. He studied neurotrophin signaling and C. elegans developmental genetics. He then pursued his PhD in Computational & Systems Biology at MIT in the labs of Profs Christopher Burge and Rudolf Jaenisch and worked on various topics on epigenetics, gene regulation and alternative splicing in stem cells, reprogramming, cancer metastasis, erythropoiesis and differentiation. Cheng and colleagues identified H3K27ac as a signature for active enhancers. He analyzed alternative splicing in epithetlial-mesenchymal transition, cancer metastasis as well as erythropoiesis and identified splicing factors regulating these processes. He constructed CRISPR-on, an artificial RNA-guided activator based on CRISPR/Cas. After graduating in 2014, he joined the Jackson Laboratory at Bar Harbor, ME, as one of the first JAX scholars where he continued to work on understanding and improving the CRISPR/Cas technology. In July 2015, he started his own lab as an assistant professor at the Jackson Laboratory for Genomic Medicine campus at Farmington, CT.